Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-05-04T01:21:36.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has been updated to reflect new dates and a version revision, indicating a recent update to the content.
    Difference
    0.5%
    Check dated 2025-04-26T17:54:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has undergone significant content changes regarding the study RIN-PF-301, including the removal of detailed descriptions of the study's design, inclusion and exclusion criteria, and efficacy assessments. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    25%
    Check dated 2025-04-19T14:14:16.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 4, 2025.
    Difference
    0.1%
    Check dated 2025-04-05T06:59:59.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-03-28T20:31:57.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect that the study is now active and not recruiting, with a total of 101 locations, including new locations in Santiago and Quillota, Chile. Additionally, several principal investigators and their contact information have been removed, indicating a significant reduction in available study contacts.
    Difference
    33%
    Check dated 2025-03-07T00:55:13.000Z thumbnail image

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.